Rheumnow Podcast

Safety of NSAIDs in Inflammatory Bowel Disease 

Screen RA ILD Properly 

Biologics Improve Sexual Function in axSpA 

Catching PsA before it Starts 

Multidimensional Pain inventory in Axial SpA 

RA: Does upfront TNFi save heartache? 

Novel Insights into Sjogren's Disease 

New Paradigms in RA Treatment 

Biomarkers in Still's and Macrophage Activation Syndrome 

"The Power of Gamma Delta T Cell for Autoimmunity" 

The Heartbreak of Sarcoidosis 

NSAID Addition Helps the Spine but not the Hips 

Durability and Safety of Bimekizumab 

Progressive BiTE in SLE 2 

Hydroxychloroquine Reduces Autoantibody Levels 

When the Back Hurts: uncovering BASDAI drivers in PsA 

The Upper Hand in PsA? Not the Dominant One 

Airway Disease in GPA 

Wired for Success: Vagal Nerve Therapy in RA 

GLP-1 in Knee Osteoarthritis 

Disparities in Physical Function in SLE 

Putting Steroid Tapering into Practice in SLE 

Tocilizumab Beats Methotrexate in GCA 

GLP-1 Receptor Agonists in PsA: Mortality and MACE

Safety of CAR-T 

ILD in Patients with Connective Tissue Disease 

SLGT-2 and GLP-1 in RA: More than Weight Loss 

PsA Predictors 

Ianalumab: Breakthrough Therapy in Sjogren's

Off the Shelf: CAR-T 

Combining CAR-T with CAR-Treg All in One 

Tapering in SELECT GCA: Steroids are the Problem 

Diagnostic Delays in PsA: A Radiographic Perspective 

Late-Breaking Trials in axSpA and PsA 

New Approaches to Therapy in PsA 

PRED-SAFE: Chronic Prednisone Use 

PsA and Brain Fog 

CAR-T Therapy: Where is it Heading? 

Join RheumNow Faculty Drs. David Liew, Antoni Chan,  Mrinalini Dey, and Jack Cush as they discuss highlights and key takeaways from the Day 2 Recap on Monday, October 27th, at the 2025 ACR Convergence meeting in Chicago.

A Nose for Vasculitis: ENT Manifestations in ANCA-Associated Disease 

Tofacitinib in AxSpA in Developing Countries 

Specialized Biomarkers in PsA 

B Cell Depletion: Check the Lymph Node 

GLP-1 and SGLT-2: Treatments Too Good to Ignore? 

Nerandomilast for ILD 

PsA: Impact of Sex 

Cellular Biomarkers of Rheumatoid Arthritis 

Using AI and LLMs in Qualitative Data 

Belimumab Before or After Immunosuppressant 

Do Patients with Rheumatic Diseases 'Weather' the Storm? 

AI in Fellow Recruitment: A New Dawn in Medical Education? 

AI Scribes Found their Favorite Doctors 

Hospitalization in Stills: Is it "Still" an Infection?

Upadacitinib is a Double Edged Vascular Sword in GCA 

Rheumatoid Arthritis: Inject the Steroids

Catching AxSpA Early: Closing the Diagnostic Gap 

Is Low Disease Activity Low Enough? 

Early Peripheral SpA: Is it okay to stop treatment sometimes?

Difficult to Manage axSpA

Big takeaways, standout moments, and what set the tone for this year’s conference. We break down the key insights, early trends, and conversations shaping Day 1.

Dr. Jack Cush reviews the news and info reports the day before ACR 2025.